Moreover, YTHDF1 overexpression holds clinical diagnostic significance across various cancers, including NSCLC, breast cancer, cervical cancer, GC, and colorectal cancer (Zhu Y. et al., 2023). Here, YTHDF1 is linked to cervical carcinoma.